American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The median citation count of American Journal of Clinical Oncology-Cancer Clinical Trials is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The Impact of the COVID-19 Pandemic on Cancer Patients247
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors128
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody35
The Impact of COVID-19 on Patients With Cancer25
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer25
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer23
Twitter23
Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors21
Angiosarcoma of the Breast21
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer20
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment19
Vaccination and Immune Checkpoint Inhibitors18
ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy18
Medical Cannabis in Cancer Patients17
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer17
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer16
Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer15
Breast and Cervical Cancer Screening Disparities in Transgender People14
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States14
Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation14
Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors13
ACR–ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT)12
A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer12
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases11
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma10
Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients10
Association Between Metabolic Syndrome and Endometrial Cancer Survival in a SEER-Medicare Linked Database10
Social Determinants of Health in Oncology10
Characterizing Urban-Rural Differences in Colon Cancer Outcomes10
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy9
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO)9
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer9
Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States9
Cancer Management During the COVID-19 Pandemic in the United States8
Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors8
Gender Differences in Outcomes of Patients With Mesothelioma8
Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer8
Food Intake During Cancer Therapy8
Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases8
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors8
Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer8
Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases7
Concurrent β-blocker Use is Associated With Improved Outcome in Esophageal Cancer Patients Who Undergo Chemoradiation7
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma7
Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)7
Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer7
Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia7
Stereotactic Body Radiotherapy and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer7
The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center7
Disparities in Surgical Recommendation for Stage I Non–Small Cell Lung Cancer7
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma7
Clinical Trials Before, During, and After COVID-19 Pandemic7
Brain Metastases From Gynecologic Malignancies7
Management Strategies for Patients With Epithelioid Hemangioendothelioma7
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases6
Proton Pump Inhibitors and Cancer Risk6
Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia6
“Was It Worth It?”6
Tumor Necrotic Debris and High Nuclear Grade6
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma6
Prior Treatment for Non–small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy6
Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma6
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer6
Survivors’ Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation6
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy6
Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period6
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer6
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections6
Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer5
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking5
Sepsis Hospitalizations With Versus Without Cancer5
Expansion of the LabBM Score5
Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy5
Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-20155
Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma5
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy5
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients5
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens5
Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases5
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database5
Six-Week Interval Between Preoperative Radiation and Surgery Is Associated With Fewer Major Wound Complications in Soft Tissue Sarcoma5
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer5
Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers5
Community-based Cancer Care Quality and Expertise in a COVID-19 Era and Beyond5
Journey to Diversity in a University Radiation Oncology Residency Program5
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer4
Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?4
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies4
Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States4
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?4
Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer4
ACR–ASTRO Practice Parameter for Communication4
Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma4
Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?4
Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder4
Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy4
Prognostic Value of Preoperative Imaging4
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast4
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy4
Comparison of Radiation Treatment Volumes for Borderline Resectable Pancreatic Cancer in Contemporary Clinical Trials4
Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer4
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)4
Concurrent Nab-paclitaxel and Radiotherapy4
Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer4
Brain Radiation Induced Extracranial Abscopal Effects in Metastatic Melanoma4
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients4
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer4
False-positive 1p/19q Testing Results in Gliomas4
Radiotherapy in Early-stage Gastric MALT4
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer4
Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique4
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy3
Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials3
Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-20153
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology3
Is There a Role for Perioperative Pelvic Radiotherapy in Surgically Resected Stage IV Rectal Cancer?3
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder3
Celecoxib and Myrtol3
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 20153
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer3
Combination Therapy for Metastatic Renal Cell Carcinoma3
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non−Small Cell Lung Cancer3
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma3
Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors3
Sacituzumab Govitecan-hziy in Breast Cancer3
Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy3
Neoadjuvant Therapy Versus Immediate Surgery for Resectable Pancreas Cancer3
Diagnostic Test Accuracy of Glasgow Prognostic Score as a Prognostic Factor for Renal Cell Carcinoma3
Transformational Changes Between Non–Small Cell and Small Cell Lung Cancer—Biological and Clinical Relevance—A Review3
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies3
Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare3
Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer3
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer3
Long-term Outcomes After Definitive Radiation Therapy for Solitary Plasmacytoma3
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-2233
Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas3
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer3
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy3
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures3
Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Wester3
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junc3
Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors3
Analyzing the Time From Discovery to Definitive Surgical Therapy for Lung Cancer Based on Referral Patterns3
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer3
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer3
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum3
Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases2
Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection2
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non–Small Cell Lung Cancer (NSCLC)2
Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma2
Pancreatic Cancer Clinical Treatment Trials Accrual2
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease2
Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate2
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei2
Cardiac Metastatic Tumors2
Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma2
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer2
Inpatient Palliative Care Use Among Critically III Brain Metastasis Patients in the United States2
The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non–Small Cell Lung Cancer2
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database2
The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma2
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy2
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation2
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation2
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer2
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity2
Accelerated Partial Breast Irradiation2
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status2
Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma2
Increased Resident Diversity Precedes Increased Faculty Diversity2
Radiotherapy for Adult Soft Tissue Sarcomas of the Head and Neck2
Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non–small Cell Lung Cancer2
Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases2
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients2
Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations2
The Immunosuppression of Etoposide Deserves Attention in Chemoimmunotherapy2
A Pilot Study of Short-course Nivolumab and Low-dose Ipilimumab for Adjuvant Treatment of Melanoma2
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer2
Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease2
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer2
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer2
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer2
Extraskeletal Myxoid Chondrosarcoma2
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer2
Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non–Small Cell Lung Cancer2
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant2
Impact of Extended Adjuvant Temozolamide Beyond 6 Months in the Management of Glioblastoma Patients2
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer2
Proceedings of the American Radium Society®’s 103rd Annual Meeting2
Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non–Small Cell Lung Cancer2
Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients2
Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy2
High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases2
Cardiovascular Diseases Following Breast Cancer2
Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-20162
Psychiatric Disturbance or Parkinsonism as a Presentation of CNS Lymphoma: Observational Retrospective Study and Review of Literature2
Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas2
Preliminary Analysis of Cervical Cancer Immunotherapy2
Proton Beam Therapy for Locally Advanced Head and Neck Tumors2
Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates2
Stereotactic Partial Breast Irradiation2
Stereotactic Body Radiotherapy for Prostate Cancer2
Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients2
Sequencing Treatments for Cancer During the COVID-19 Pandemic2
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer2
0.032217025756836